{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:27:28Z","timestamp":1791073648630,"version":"4.1.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.vaccine.2011.11.090","type":"journal-article","created":{"date-parts":[[2012,4,7]],"date-time":"2012-04-07T13:26:24Z","timestamp":1333805184000},"page":"D116-D125","source":"Crossref","is-referenced-by-count":53,"special_numbering":"S4","title":["\u201cIDEAL\u201d vaccines for resource poor settings"],"prefix":"10.1016","volume":"29","author":[{"given":"Myron M.","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"July (9789)","key":"10.1016\/j.vaccine.2011.11.090_bib0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(11)60406-6","article-title":"The future of immunisation policy, implementation, and financing","volume":"378","author":"Levine","year":"2011","journal-title":"Lancet"},{"issue":"July (24)","key":"10.1016\/j.vaccine.2011.11.090_bib0010","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1016\/S0264-410X(03)00347-5","article-title":"Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative","volume":"21","author":"Vandelaer","year":"2003","journal-title":"Vaccine"},{"issue":"December (9603)","key":"10.1016\/j.vaccine.2011.11.090_bib0015","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)61261-6","article-title":"Maternal and neonatal tetanus","volume":"370","author":"Roper","year":"2007","journal-title":"Lancet"},{"issue":"July (Suppl. 1)","key":"10.1016\/j.vaccine.2011.11.090_bib0020","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1093\/infdis\/jir116","article-title":"Measles mortality reduction and pre-elimination in the African region, 2001\u20132009","volume":"204","author":"Masresha","year":"2011","journal-title":"J Infect Dis"},{"issue":"July (Suppl. 1)","key":"10.1016\/j.vaccine.2011.11.090_bib0025","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1093\/infdis\/jir109","article-title":"Progress in measles mortality reduction in Ethiopia, 2002\u20132009","volume":"204","author":"Mitiku","year":"2011","journal-title":"J Infect Dis"},{"issue":"April (19)","key":"10.1016\/j.vaccine.2011.11.090_bib0030","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.vaccine.2010.02.066","article-title":"Using oral polio vaccine beyond the cold chain: a feasibility study conducted during the national immunization campaign in Mali","volume":"28","author":"Halm","year":"2010","journal-title":"Vaccine"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.11.090_bib0035","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/320729","article-title":"An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine","volume":"183","author":"Yang","year":"2001","journal-title":"J Infect Dis"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2011.11.090_bib0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1741-7015-6-3","article-title":"Yellow fever control in Cameroon: where are we now and where are we going?","volume":"3","author":"Wiysonge","year":"2008","journal-title":"BMC Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0045","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1371\/journal.pntd.0001006","article-title":"Use of oral cholera vaccines in an outbreak in Vietnam: a case control study","volume":"5","author":"Anh","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"October (39)","key":"10.1016\/j.vaccine.2011.11.090_bib0050","first-page":"994","article-title":"Distribution of insecticide-treated bednets during an integrated nationwide immunization campaign\u2014Togo, West Africa, December 2004","volume":"54","author":"Takpa","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.11.090_bib0055","first-page":"684","article-title":"Evaluating the experience of GAPS\u2014a methodology for improving quality of mass immunization campaigns in developing countries","volume":"27","author":"Weiss","year":"2009","journal-title":"J Health Popul Nutr"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.11.090_bib0060","first-page":"449","article-title":"An evaluation of infant immunization in Africa: is a transformation in progress?","volume":"85","author":"Arevshatian","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"October","key":"10.1016\/j.vaccine.2011.11.090_bib0065","article-title":"From emergence to eradication: the epidemiology of poliomyelitis deconstructed","author":"Nathanson","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"July (9480)","key":"10.1016\/j.vaccine.2011.11.090_bib0070","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(05)66788-8","article-title":"Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study","volume":"366","author":"Adegbola","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2011.11.090_bib0075","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4269\/ajtmh.2009.80.1033","article-title":"Haemophilus influenzae type b conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection","volume":"80","author":"Sow","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.vaccine.2011.11.090_bib0080","first-page":"789","article-title":"Unsafe injections in the developing world and transmission of bloodborne pathogens: a review","volume":"77","author":"Simonsen","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"10","key":"10.1016\/j.vaccine.2011.11.090_bib0085","first-page":"801","article-title":"Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates","volume":"77","author":"Kane","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"October","key":"10.1016\/j.vaccine.2011.11.090_bib0090","article-title":"Introducing pentavalent vaccine in EPI in India: issues involved","volume":"132","author":"John","year":"2010","journal-title":"Indian J Med Res"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2011.11.090_bib0095","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.vaccine.2008.12.037","article-title":"Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia","volume":"27","author":"Griffiths","year":"2009","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm0103-99","article-title":"Can needle-free administration of vaccines become the norm in global immunization?","volume":"9","author":"Levine","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0105","first-page":"699","article-title":"Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine","volume":"27","author":"Groot","year":"1962","journal-title":"Bull World Health Organ"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2011.11.090_bib0110","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.11.090_bib0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/infdis\/125.2.161","article-title":"Smallpox in Europe, 1950\u20131971","volume":"125","author":"Mack","year":"1972","journal-title":"J Infect Dis"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0120","first-page":"112","article-title":"Duration of immunity after smallpox vaccination: a study on vaccination policy against smallpox bioterrorism in Japan","volume":"55","author":"Arita","year":"2002","journal-title":"Jpn J Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.11.090_bib0125","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.vaccine.2011.11.090_bib0130","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/498902","article-title":"Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy","volume":"42","author":"Marin","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.11.090_bib0140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1017\/S0950268800057824","article-title":"Measles vaccine: a 27-year follow-up","volume":"112","author":"Ramsay","year":"1994","journal-title":"Epidemiol Infect"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.11.090_bib0145","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/00006454-199612000-00005","article-title":"Measles vaccine effectiveness and duration of vaccine-induced immunity in the absence of boosting from exposure to measles virus","volume":"15","author":"Guris","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2011.11.090_bib0150","first-page":"779","article-title":"Comparative trial of live measles vaccines in Czechoslovakia","volume":"32","author":"Syrucek","year":"1965","journal-title":"Bull World Health Organ"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.11.090_bib0155","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-3476(73)80107-6","article-title":"Failures of protection by measles vaccine","volume":"82","author":"Plotkin","year":"1973","journal-title":"J Pediatr"},{"issue":"August (9)","key":"10.1016\/j.vaccine.2011.11.090_bib0160","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM198508293130904","article-title":"Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses","volume":"313","author":"Halsey","year":"1985","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.11.090_bib0165","first-page":"375","article-title":"Comparative trial of live attenuated measles vaccine in Hong Kong by intramuscular and intradermal injection","volume":"36","author":"Anonymous","year":"1967","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-0-387-34814-8_3","article-title":"Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D","volume":"590","author":"Querec","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.11.090_bib0175","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"issue":"January (5963)","key":"10.1016\/j.vaccine.2011.11.090_bib0185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1183021","article-title":"Regulation of adaptive immunity by the innate immune system","volume":"327","author":"Iwasaki","year":"2010","journal-title":"Science"},{"issue":"April","key":"10.1016\/j.vaccine.2011.11.090_bib0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7007-8-37","article-title":"Immune mechanisms of protection: can adjuvants rise to the challenge?","volume":"8","author":"McKee","year":"2010","journal-title":"BMC Biol"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2011.11.090_bib0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2007.11.003","article-title":"How do adjuvants work? Important considerations for new generation adjuvants","volume":"27","author":"McKee","year":"2007","journal-title":"Immunity"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.11.090_bib0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/erv.09.160","article-title":"Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists","volume":"9","author":"Black","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0205","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/JVI.01597-10","article-title":"Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors","volume":"85","author":"Rhee","year":"2011","journal-title":"J Virol"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0210","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0215","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1586\/erv.11.26","article-title":"T.L.R-7 and -8 agonists as vaccine adjuvants","volume":"10","author":"Tomai","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0220","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","article-title":"Use of defined TLR ligands as adjuvants within human vaccines","volume":"239","author":"Duthie","year":"2011","journal-title":"Immunol Rev"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2011.11.090_bib0225","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.11.090_bib0240","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2007-09-110858","article-title":"APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells","volume":"111","author":"Belnoue","year":"2008","journal-title":"Blood"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0245","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/QCO.0b013e328345d563","article-title":"Neonatal immunization: where do we stand?","volume":"24","author":"Wood","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ni0311-189","article-title":"Challenges in infant immunity: implications for responses to infection and vaccines","volume":"12","author":"PrabhuDas","year":"2011","journal-title":"Nat Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0255","doi-asserted-by":"crossref","first-page":"e18185","DOI":"10.1371\/journal.pone.0018185","article-title":"Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants","volume":"6","author":"Burl","year":"2011","journal-title":"PLoS One"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2011.11.090_bib0260","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.4049\/jimmunol.0901481","article-title":"Neonatal innate TLR-mediated responses are distinct from those of adults","volume":"183","author":"Kollmann","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.11.090_bib0265","doi-asserted-by":"crossref","first-page":"e3683","DOI":"10.1371\/journal.pone.0003683","article-title":"Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant","volume":"3","author":"Kamath","year":"2008","journal-title":"PLoS One"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0270","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.arr.2010.09.005","article-title":"Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience","volume":"10","author":"Lang","year":"2011","journal-title":"Ageing Res Rev"},{"issue":"April (19)","key":"10.1016\/j.vaccine.2011.11.090_bib0275","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.vaccine.2011.02.094","article-title":"Antibody responses to natural influenza A\/H1N1\/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children","volume":"29","author":"Meier","year":"2011","journal-title":"Vaccine"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0280","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/653112","article-title":"Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial","volume":"51","author":"Sogaard","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.11.090_bib0285","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/INF.0b013e31819d6394","article-title":"Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"September (14)","key":"10.1016\/j.vaccine.2011.11.090_bib0290","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/01.aids.0000183514.37513.d2","article-title":"CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults","volume":"19","author":"Cooper","year":"2005","journal-title":"AIDS"},{"issue":"May","key":"10.1016\/j.vaccine.2011.11.090_bib0295","article-title":"Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)","author":"Taylor","year":"2011","journal-title":"Vaccine"},{"issue":"September (27\u201328)","key":"10.1016\/j.vaccine.2011.11.090_bib0300","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1016\/j.vaccine.2004.03.025","article-title":"Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy","volume":"22","author":"Vindurampulle","year":"2004","journal-title":"Vaccine"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0305","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1086\/596066","article-title":"Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine","volume":"199","author":"Galen","year":"2009","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.11.090_bib0310","doi-asserted-by":"crossref","first-page":"e9015","DOI":"10.1371\/journal.pone.0009015","article-title":"Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses","volume":"5","author":"Koup","year":"2010","journal-title":"PLoS One"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0315","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/hv.6.1.10116","article-title":"Prime-boost vectored malaria vaccines: progress and prospects","volume":"6","author":"Hill","year":"2010","journal-title":"Hum Vaccine"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2011.11.090_bib0320","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"issue":"June","key":"10.1016\/j.vaccine.2011.11.090_bib0325","article-title":"Vaccine stabilization: research, commercialization, and potential impact","author":"Kristensen","year":"2011","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0330","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/hv.5.1.6494","article-title":"Characterization of the freeze sensitivity of a hepatitis B vaccine","volume":"5","author":"Chen","year":"2009","journal-title":"Hum Vaccine"},{"issue":"May (Suppl. 3)","key":"10.1016\/j.vaccine.2011.11.090_bib0335","doi-asserted-by":"crossref","first-page":"S613","DOI":"10.1093\/clinids\/11.Supplement_3.S613","article-title":"Improving the heat stability of vaccines: problems, needs, and approaches","volume":"11","author":"Hilleman","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"July (31)","key":"10.1016\/j.vaccine.2011.11.090_bib0340","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1016\/j.vaccine.2011.04.079","article-title":"Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay","volume":"29","author":"Schlehuber","year":"2011","journal-title":"Vaccine"},{"issue":"March (15)","key":"10.1016\/j.vaccine.2011.11.090_bib0345","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.vaccine.2011.01.093","article-title":"Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines","volume":"29","author":"Ohtake","year":"2011","journal-title":"Vaccine"},{"issue":"September (2)","key":"10.1016\/j.vaccine.2011.11.090_bib0350","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/cryo.2001.2353","article-title":"The trehalose myth revisited: introduction to a symposium on stabilization of cells in the dry state","volume":"43","author":"Crowe","year":"2001","journal-title":"Cryobiology"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.11.090_bib0355","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.3390\/ijms10093793","article-title":"Trehalose metabolism: from osmoprotection to signaling","volume":"10","author":"Iturriaga","year":"2009","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0360","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-0-387-39975-1_13","article-title":"Trehalose as a chemical chaperone: fact and fantasy","volume":"594","author":"Crowe","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"August (35)","key":"10.1016\/j.vaccine.2011.11.090_bib0365","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1016\/j.vaccine.2007.06.054","article-title":"Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying","volume":"25","author":"Amorij","year":"2007","journal-title":"Vaccine"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2011.11.090_bib0370","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","article-title":"A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats","volume":"23","author":"Huang","year":"2004","journal-title":"Vaccine"},{"issue":"February (19)","key":"10.1016\/j.vaccine.2011.11.090_bib0375","doi-asserted-by":"crossref","first-page":"19ra12","DOI":"10.1126\/scitranslmed.3000490","article-title":"Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass","volume":"2","author":"Alcock","year":"2010","journal-title":"Sci Transl Med"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0380","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(00)80106-3","article-title":"Epithelial M cells: gateways for mucosal infection and immunization","volume":"86","author":"Neutra","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0385","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-065X.1999.tb01339.x","article-title":"Mucosal immunity and tolerance: relevance to vaccine development","volume":"August (170)","author":"Czerkinsky","year":"1999","journal-title":"Immunol Rev"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0390","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol Rev"},{"issue":"October (Suppl 2)","key":"10.1016\/j.vaccine.2011.11.090_bib0395","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0400","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of cholera vaccines in Bangladesh: results from three year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0410","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0415","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0420","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent human-bovine reassortant rotavirus vaccine against severe rotavirus gastroenteritis in sub-Saharan Africa: a randomized, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2011.11.090_bib0425","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"issue":"October","key":"10.1016\/j.vaccine.2011.11.090_bib0430","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","author":"Sur","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0435","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0020-2452(96)85758-7","article-title":"Live oral cholera vaccine: from principle to product","volume":"93","author":"Levine","year":"1995","journal-title":"Bull Inst Pasteur"},{"issue":"June (19)","key":"10.1016\/j.vaccine.2011.11.090_bib0440","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.vaccine.2003.11.070","article-title":"Can oral cholera vaccination play a role in controlling a cholera outbreak?","volume":"22","author":"Calain","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.11.090_bib0445","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.aje.a121457","article-title":"Oral polio vaccination of children in the tropics I. The poor seroconversion rates and the absence of viral interference","volume":"96","author":"John","year":"1972","journal-title":"Am J Epidemiol"},{"issue":"November (1\u20132)","key":"10.1016\/j.vaccine.2011.11.090_bib0450","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0264-410X(02)00348-1","article-title":"Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children","volume":"21","author":"Hallander","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0455","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0140-6736(92)92231-4","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5\u20139-year-old Indonesian children","volume":"340","author":"Suharyono Simanjuntak","year":"1992","journal-title":"Lancet"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0460","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/mi.2009.22","article-title":"Enteric vaccines for the developing world: a challenge for mucosal immunology","volume":"2","author":"Czerkinsky","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0465","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(05)79439-3","article-title":"Optimism over vaccines administered via mucosal surfaces","volume":"351","author":"Levine","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0470","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0264-410X(92)90420-O","article-title":"Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine","volume":"10","author":"Chatfield","year":"1992","journal-title":"Vaccine"},{"issue":"6\u20137","key":"10.1016\/j.vaccine.2011.11.090_bib0475","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0264-410X(96)00227-7","article-title":"A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens","volume":"15","author":"Galen","year":"1997","journal-title":"Vaccine"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2011.11.090_bib0480","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/clim.2000.4924","article-title":"Safety and immune responses to attenuated Salmonella enterica Serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C","volume":"97","author":"Tacket","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0485","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1128\/IAI.64.10.4172-4181.1996","article-title":"Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908","volume":"64","author":"Barry","year":"1996","journal-title":"Infect Immun"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2011.11.090_bib0490","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.86.17.6763","article-title":"Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus","volume":"86","author":"Lubeck","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.vaccine.2011.11.090_bib0495","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0264-410X(92)90088-2","article-title":"Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine","volume":"10","author":"Tacket","year":"1992","journal-title":"Vaccine"},{"issue":"May","key":"10.1016\/j.vaccine.2011.11.090_bib0500","article-title":"Salmonella enterica serovar Typhi live vector vaccines finally come of age","author":"Galen","year":"2009","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.11.090_bib0505","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1615\/CritRevImmunol.v30.i3.30","article-title":"New technologies in using recombinant attenuated Salmonella vaccine vectors","volume":"30","author":"Curtiss","year":"2010","journal-title":"Crit Rev Immunol"},{"issue":"December (10)","key":"10.1016\/j.vaccine.2011.11.090_bib0510","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3109\/1061186X.2010.529143","article-title":"Bioadhesive delivery systems for mucosal vaccine delivery","volume":"18","author":"Baudner","year":"2010","journal-title":"J Drug Target"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.11.090_bib0515","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1586\/14760584.6.5.797","article-title":"Nanoparticles and microparticles as vaccine-delivery systems","volume":"6","author":"Singh","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0520","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0264-410X(94)80038-2","article-title":"Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA\/II encapsulated in biodegradable microspheres","volume":"12","author":"Tacket","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.090_bib0525","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/315653","article-title":"Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes","volume":"182","author":"Tacket","year":"2000","journal-title":"J Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.11.090_bib0530","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1128\/IAI.64.12.5219-5224.1996","article-title":"Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain","volume":"64","author":"Nardelli-Haefliger","year":"1996","journal-title":"Infect Immun"},{"issue":"20","key":"10.1016\/j.vaccine.2011.11.090_bib0535","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"N Engl J Med"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2011.11.090_bib0540","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1056\/NEJMoa055414","article-title":"Effectiveness of school-based influenza vaccination","volume":"355","author":"King","year":"2006","journal-title":"N Engl J Med"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0545","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1542\/peds.2007-2963","article-title":"Countywide school-based influenza immunization: direct and indirect impact on student absenteeism","volume":"122","author":"Davis","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0550","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.47.4.510-550.1983","article-title":"New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development","volume":"47","author":"Levine","year":"1983","journal-title":"Microbiol Rev"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0555","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/315337","article-title":"Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant","volume":"181","author":"Gluck","year":"2000","journal-title":"J Infect Dis"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2011.11.090_bib0560","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"October (4\u20135)","key":"10.1016\/j.vaccine.2011.11.090_bib0565","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1438-4221(00)80064-8","article-title":"LTR72, two mucosal adjuvants ready for clinical trials","volume":"290","author":"Pizza","year":"2000","journal-title":"Int J Med Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.11.090_bib0570","doi-asserted-by":"crossref","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell\u2018s palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS One"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0575","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.162.4.2432","article-title":"Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity","volume":"162","author":"Agren","year":"1999","journal-title":"J Immunol"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2011.11.090_bib0580","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mi.2010.54","article-title":"Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins","volume":"3","author":"Lycke","year":"2010","journal-title":"Mucosal Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.11.090_bib0585","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/IAI.71.2.726-732.2003","article-title":"Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a","volume":"71","author":"Mills","year":"2003","journal-title":"Infect Immun"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2011.11.090_bib0590","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1086\/657087","article-title":"Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues","volume":"202","author":"El-Kamary","year":"2010","journal-title":"J Infect Dis"},{"issue":"May (Suppl. 1)","key":"10.1016\/j.vaccine.2011.11.090_bib0595","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1086\/368227","article-title":"Ensuring injection safety during measles immunization campaigns: more than auto-disable syringes and safety boxes","volume":"187","author":"Hersh","year":"2003","journal-title":"J Infect Dis"},{"issue":"May (Suppl. 1)","key":"10.1016\/j.vaccine.2011.11.090_bib0600","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1086\/368049","article-title":"Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues","volume":"187","author":"Pless","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.11.090_bib0605","first-page":"163","article-title":"Safety of immunization injections in Africa: not simply a problem of logistics","volume":"78","author":"Dicko","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0610","first-page":"1019","article-title":"Hidden reality on the introduction of auto-disable syringes in developing countries","volume":"35","author":"Kuroiwa","year":"2004","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.11.090_bib0615","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4161\/hv.3.2.3877","article-title":"A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults","volume":"3","author":"Simon","year":"2007","journal-title":"Hum Vaccine"},{"issue":"March (9206)","key":"10.1016\/j.vaccine.2011.11.090_bib0620","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0140-6736(99)95140-1","article-title":"Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial","volume":"355","author":"Dilraj","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.090_bib0625","first-page":"53","article-title":"La vacunacion antisarampionosa en Mexico por el metodo de aerosol","volume":"39","author":"Fernandez-de Castro","year":"1997","journal-title":"Salud Publica Mex Jan"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0630","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.vaccine.2007.11.010","article-title":"Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis","volume":"26","author":"Low","year":"2008","journal-title":"Vaccine"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.11.090_bib0635","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.1983.03330430027025","article-title":"Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines","volume":"249","author":"Sabin","year":"1983","journal-title":"JAMA"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0640","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4161\/hv.1.1.1423","article-title":"A meta-analysis of studies comparing the respiratory route with the subcutaneous route of measles vaccine administration","volume":"1","author":"Hiremath","year":"2005","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0645","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/3-540-36583-4_10","article-title":"Measles aerosol vaccination","volume":"304","author":"Valdespino-Gomez","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0650","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/biol.1997.0103","article-title":"Alternative routes of measles immunization: a review","volume":"25","author":"Cutts","year":"1997","journal-title":"Biologicals"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2011.11.090_bib0655","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1016\/j.vaccine.2007.03.003","article-title":"Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination","volume":"25","author":"Dilraj","year":"2007","journal-title":"Vaccine"},{"issue":"September (40\u201341)","key":"10.1016\/j.vaccine.2011.11.090_bib0660","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1016\/j.vaccine.2006.05.125","article-title":"Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety","volume":"24","author":"de Swart","year":"2006","journal-title":"Vaccine"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2011.11.090_bib0665","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1073\/pnas.1017334108","article-title":"Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques","volume":"108","author":"Lin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.090_bib0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i1.10","article-title":"Dry powder nasal vaccines as an alternative to needle-based delivery","volume":"26","author":"Hickey","year":"2009","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"March (13\u201314)","key":"10.1016\/j.vaccine.2011.11.090_bib0675","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0264-410X(98)00438-1","article-title":"Dry powder inhalation as a potential delivery method for vaccines","volume":"17","author":"LiCalsi","year":"1999","journal-title":"Vaccine"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.11.090_bib0680","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4161\/hv.4.5.5863","article-title":"Stabilization of measles virus for vaccine formulation","volume":"4","author":"Kissmann","year":"2008","journal-title":"Hum Vaccine"},{"issue":"January (7)","key":"10.1016\/j.vaccine.2011.11.090_bib0685","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.vaccine.2006.10.019","article-title":"Measles vaccination of macaques by dry powder inhalation","volume":"25","author":"de Swart","year":"2007","journal-title":"Vaccine"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2011.11.090_bib0690","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1073\/pnas.0800043105","article-title":"Immunization by a bacterial aerosol","volume":"105","author":"Garcia-Contreras","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2011.11.090_bib0695","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.0611430104","article-title":"Drying a tuberculosis vaccine without freezing","volume":"104","author":"Wong","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2011.11.090_bib0700","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","article-title":"Needle-free vaccine delivery","volume":"58","author":"Giudice","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0705","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/milmed\/128.6.516","article-title":"The historical development of jet injection and envisioned uses in mass immunization and mass therapy based upon two decades experience","volume":"128","author":"Hingson","year":"1963","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0710","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3928\/0090-4481-19980601-12","article-title":"Taking the sting out of shots: control of vaccination-associated pain and adverse reactions","volume":"27","author":"Cohen Reis","year":"1998","journal-title":"Pediatr Ann"},{"issue":"September (32)","key":"10.1016\/j.vaccine.2011.11.090_bib0715","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1016\/S0264-410X(01)00225-0","article-title":"Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors","volume":"19","author":"Jackson","year":"2001","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.11.090_bib0720","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1001\/archinte.1990.00390200105020","article-title":"An outbreak of hepatitis B associated with jet injections in a weight reduction clinic","volume":"150","author":"Canter","year":"1990","journal-title":"Arch Intern Med"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2011.11.090_bib0725","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.vaccine.2007.12.041","article-title":"Preventing contamination between injections with multiple-use nozzle needle-free injectors: a safety trial","volume":"26","author":"Kelly","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0730","series-title":"Vaccines","first-page":"1357","article-title":"Alternative vaccine delivery methods","author":"Weniger","year":"2008"},{"issue":"October","key":"10.1016\/j.vaccine.2011.11.090_bib0735","article-title":"Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector","author":"Simon","year":"2011","journal-title":"Vaccine"},{"issue":"February (13\u201314)","key":"10.1016\/j.vaccine.2011.11.090_bib0740","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0264-410X(00)00358-3","article-title":"Ensuring vaccine safety in immunization programmes\u2014a WHO perspective","volume":"19","author":"Jodar","year":"2001","journal-title":"Vaccine"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0745","first-page":"449","article-title":"Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule): comparison with standard syringe injection. Imule Investigators Group","volume":"15","author":"Parent dC","year":"1997","journal-title":"Vaccine"},{"issue":"November (7\u20138)","key":"10.1016\/j.vaccine.2011.11.090_bib0750","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","article-title":"Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine","volume":"19","author":"Roy","year":"2000","journal-title":"Vaccine"},{"issue":"April (5)","key":"10.1016\/j.vaccine.2011.11.090_bib0755","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAI.0b013e3180417cb6","article-title":"Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects","volume":"44","author":"Tavel","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.11.090_bib0760","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/509259","article-title":"Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine","volume":"194","author":"Graham","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0765","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/36014","article-title":"Skin immunization made possible by cholera toxin","volume":"391","author":"Glenn","year":"1998","journal-title":"Nature"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.11.090_bib0770","article-title":"Transcutaneous and Intradermal vaccination","volume":"7","author":"Combadiere","year":"2011","journal-title":"Hum Vaccine"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2011.11.090_bib0775","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2010.09.018","article-title":"Advances in transcutaneous vaccine delivery: do all ways lead to Rome?","volume":"148","author":"Bal","year":"2010","journal-title":"J Control Release"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2011.11.090_bib0780","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14760584.7.8.1201","article-title":"Intradermal epidermal and transcutaneous vaccination: from immunology to clinical practice","volume":"7","author":"Nicolas","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0785","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-3-540-92165-3_17","article-title":"Transcutaneous immunization with influenza vaccines","volume":"333","author":"Skountzou","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0790","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/IAI.70.4.1874-1880.2002","article-title":"Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously","volume":"70","author":"Guerena-Burgueno","year":"2002","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.11.090_bib0795","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.inf.0000164768.28135.0d","article-title":"Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine","volume":"24","author":"Sow","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.11.090_bib0800","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.inf.0000232629.72160.bb","article-title":"Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys","volume":"25","author":"Tapia","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.11.090_bib0805","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-3156.1998.00227.x","article-title":"A comparison of oral fluid and serum for the detection of rubella-specific antibodies in a community study in Addis Ababa, Ethiopia","volume":"3","author":"Nokes","year":"1998","journal-title":"Trop Med Int Health"},{"issue":"7","key":"10.1016\/j.vaccine.2011.11.090_bib0810","first-page":"588","article-title":"Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia","volume":"79","author":"Nokes","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"September (37)","key":"10.1016\/j.vaccine.2011.11.090_bib0815","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.vaccine.2008.07.005","article-title":"Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys","volume":"26","author":"Nigatu","year":"2008","journal-title":"Vaccine"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.11.090_bib0820","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/jmv.20750","article-title":"Serological and molecular epidemiology of measles virus outbreaks reported in Ethiopia during 2000\u20132004","volume":"78","author":"Nigatu","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2011.11.090_bib0825","series-title":"New generation vaccines","first-page":"91","article-title":"Reaching every child: achieving equity in global immunization","author":"Aylward","year":"2009"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101886X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101886X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T21:04:54Z","timestamp":1687381494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1101886X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":165,"alternative-id":["S0264410X1101886X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.090","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}